日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma

利用可诱导的白细胞介素-12 基因工程改造肿瘤浸润淋巴细胞,用于转移性黑色素瘤的免疫治疗

Ling Zhang, Richard A Morgan, Joal D Beane, Zhili Zheng, Mark E Dudley, Sadik H Kassim, Azam V Nahvi, Lien T Ngo, Richard M Sherry, Giao Q Phan, Marybeth S Hughes, Udai S Kammula, Steven A Feldman, Mary Ann Toomey, Sid P Kerkar, Nicholas P Restifo, James C Yang, Steven A Rosenberg

Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application

评估介导IL-12诱导表达的γ逆转录病毒载体在临床应用中的潜力

Zhang, Ling; Feldman, Steven A; Zheng, Zhili; Chinnasamy, Nachimuthu; Xu, Hui; Nahvi, Azam V; Dudley, Mark E; Rosenberg, Steven A; Morgan, Richard A

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

利用基因工程改造的、对 NY-ESO-1 有反应的淋巴细胞,可使转移性滑膜细胞肉瘤和黑色素瘤患者的肿瘤消退

Robbins, Paul F; Morgan, Richard A; Feldman, Steven A; Yang, James C; Sherry, Richard M; Dudley, Mark E; Wunderlich, John R; Nahvi, Azam V; Helman, Lee J; Mackall, Crystal L; Kammula, Udai S; Hughes, Marybeth S; Restifo, Nicholas P; Raffeld, Mark; Lee, Chyi-Chia Richard; Levy, Catherine L; Li, Yong F; El-Gamil, Mona; Schwarz, Susan L; Laurencot, Carolyn; Rosenberg, Steven A